202 related articles for article (PubMed ID: 37031550)
1. Factors influencing prognosis and relapse in patients with anti-N-methyl-D-aspartate receptor encephalitis.
Wu Q; Xie Q; Liu L; Meng C; Wang J
Mult Scler Relat Disord; 2023 Jun; 74():104697. PubMed ID: 37031550
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
[No Abstract] [Full Text] [Related]
3. [Immunotherapy strategy for 35 cases of severe anti-N-methyl-D-aspartate receptor encephalitis].
Yuan J; Peng B; Guan HZ; Huang Y; Lu Q; Ren HT; Yang XZ; Jiang N; Zhu YC; Cui LY
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1035-9. PubMed ID: 27055797
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of anti
Zheng J; Shen J; Wang A; Liu L; Xiong J; Li X; Xiao Y; Li J; Mao D; Liu L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 45(1):47-54. PubMed ID: 32132297
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and long-term prognosis of relapsing anti-N-methyl-D-aspartate receptor encephalitis: a retrospective, multicenter, self-controlled study.
Zeng W; Cao L; Zheng J; Yu L
Neurol Sci; 2021 Jan; 42(1):199-207. PubMed ID: 32601745
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Features and Prognosis of Anti-NMDAR Encephalitis Depends on Blood Brain Barrier Integrity.
Yu Y; Wu Y; Cao X; Li J; Liao X; Wei J; Huang W
Mult Scler Relat Disord; 2021 Jan; 47():102604. PubMed ID: 33130468
[TBL] [Abstract][Full Text] [Related]
7. Pediatric anti-N-methyl-d-aspartate receptor encephalitis in southern China: Analysis of 111 cases.
Li X; Hou C; Wu WL; Liang H; Zheng K; Zhang Y; Zeng Y; Chen L; Zhu H; Tian Y; Gao Y; Peng B; Yang S; Wang X; Ning S; Liao Y; Lin H; Chen WX
J Neuroimmunol; 2021 Mar; 352():577479. PubMed ID: 33486307
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the risk factors for poor prognosis and recurrence in patients with anti-NMDAR encephalitis].
Wu Q; Wang XN; Yang QL; Liu L; Peng YJ; Qiao ZX; Wang JW
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Feb; 57(2):247-252. PubMed ID: 36797584
[TBL] [Abstract][Full Text] [Related]
9. Clinical and radiological features, treatment responses and prognosis in pediatric patients with co-existing anti-N-methyl-D-aspartate receptor and myelin oligodendrocyte glycoprotein antibody-associated encephalitis: A single center study.
Liao D; Zhong L; Yang L; He F; Deng X; Yin F; Peng J
Mult Scler Relat Disord; 2024 Jan; 81():105133. PubMed ID: 37984120
[TBL] [Abstract][Full Text] [Related]
10. Brain magnetic resonance imaging as predictors in pediatric anti-N-methyl-D-aspartate receptor encephalitis.
Hou C; Li X; Zeng Y; Gao Y; Wu W; Zhu H; Zhang Y; Wu W; Tian Y; Zheng K; Chen L; Peng B; Chen WX
Mult Scler Relat Disord; 2024 Feb; 82():105061. PubMed ID: 38134605
[TBL] [Abstract][Full Text] [Related]
11. Immune characteristics of children with autoimmune encephalitis and the correlation with a short-term prognosis.
Huang JY; Fan WX; Meng J; Cai CQ; Li D
Ital J Pediatr; 2022 Jun; 48(1):94. PubMed ID: 35698204
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Risk Factors for a Poor Prognosis in Patients with Anti-
Mo Y; Wang L; Zhu L; Li F; Yu G; Luo Y; Ni M
J Clin Neurol; 2020 Jul; 16(3):438-447. PubMed ID: 32657065
[TBL] [Abstract][Full Text] [Related]
13. High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis.
Wang J; Lin J; Wang M; Meng Z; Zhou D; Li J
Front Immunol; 2021; 12():774664. PubMed ID: 34975861
[TBL] [Abstract][Full Text] [Related]
14. Temporal rank of clinical characteristics and prognosis of anti-N-methyl-d-aspartate receptor encephalitis.
Yang R; Ge F; Jiang J; Wang Y; Wan M; Zhang W
Brain Behav; 2021 Aug; 11(8):e2277. PubMed ID: 34232562
[TBL] [Abstract][Full Text] [Related]
15. Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes.
Wang Y; Zhang W; Yin J; Lu Q; Yin F; He F; Peng J
J Neuroimmunol; 2017 Nov; 312():59-65. PubMed ID: 28935354
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma.
Dai Y; Zhang J; Ren H; Zhou X; Chen J; Cui L; Lang J; Guan H; Sun D
Am J Obstet Gynecol; 2019 Nov; 221(5):485.e1-485.e10. PubMed ID: 31128109
[TBL] [Abstract][Full Text] [Related]
17. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis.
Nosadini M; Eyre M; Molteni E; Thomas T; Irani SR; Dalmau J; Dale RC; Lim M; ; Anlar B; Armangue T; Benseler S; Cellucci T; Deiva K; Gallentine W; Gombolay G; Gorman MP; Hacohen Y; Jiang Y; Lim BC; Muscal E; Ndondo A; Neuteboom R; Rostásy K; Sakuma H; Sartori S; Sharma S; Tenembaum SN; Van Mater HA; Wells E; Wickstrom R; Yeshokumar AK
JAMA Neurol; 2021 Nov; 78(11):1333-1344. PubMed ID: 34542573
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors and Prognosis in Anti-NMDA Receptor Encephalitis Patients with Disturbance of Consciousness.
Gong Z; Lao D; Huang F; Lv S; Mao F; Huang W
Patient Relat Outcome Meas; 2023; 14():181-192. PubMed ID: 37337520
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Short-Term Prognosis of Autoimmune Encephalitis: A Single-Center Cohort Study in Changsha, China.
Deng S; Qiu K; Liu H; Wu X; Lei Q; Lu W
Front Neurol; 2019; 10():539. PubMed ID: 31178819
[No Abstract] [Full Text] [Related]
20. Relapse factors of patients of anti-N-methyl-D-aspartate receptor encephalitis.
Zhao YY; Wang HX; Wang M; Yuan B; Sun TW; Xu YM
Acta Neurol Scand; 2022 Apr; 145(4):434-441. PubMed ID: 34927233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
